Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epitranscriptomics in liver disease: Basic concepts and therapeutic potential
Zhicong Zhao, Jiaxiang Meng, Rui Su, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 664-679
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 425
ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
Yunhao Chen, Yanchun Zhao, Junru Chen, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 222
Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma
Yeming Yang, Jingshu Cai, Xue Yang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2342-2353
Open Access | Times Cited: 118
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 43
FTO deficiency in older livers exacerbates ferroptosis during ischaemia/reperfusion injury by upregulating ACSL4 and TFRC
Rong Li, Xijing Yan, Cuicui Xiao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease
Zishan Peng, Yingying Gong, Xuejie Wang, et al.
Molecular Therapy (2021) Vol. 30, Iss. 2, pp. 932-946
Open Access | Times Cited: 76
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins
Jingyu Liao, Yi Wei, Junnan Liang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 58
Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a
Yan Xu, Zhuowei Zhou, Xinmei Kang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis
Yanli Li, Xinmei Kang, Zhuowei Zhou, et al.
Molecular Therapy (2022) Vol. 30, Iss. 12, pp. 3714-3728
Open Access | Times Cited: 43
The role of RNA m6A methylation in lipid metabolism
Yuting Wang, Yujie Wang, Jiarui Gu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39
ALKBH5‐mediated m6A demethylation of TIRAP mRNA promotes radiation‐induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma
Yuhan Chen, Peitao Zhou, Yixun Deng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 31
IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis
Ji-Fei Ding, He Sun, Kai Song, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175494-175494
Closed Access | Times Cited: 24
N6-methyladenosine RNA methylation in diabetic kidney disease
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 10
RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis
Siming Qu, Jin Li, Hanfei Huang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases
Xianhui Zeng, Xianglei Yuan, Qiuyu Cai, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1945-1945
Open Access | Times Cited: 47
The potential role of m6A RNA methylation in diabetic retinopathy
Nidhi Kumari, Aditi Karmakar, Md Maqsood Ahamad Khan, et al.
Experimental Eye Research (2021) Vol. 208, pp. 108616-108616
Closed Access | Times Cited: 43
Mechanism of cancer stemness maintenance in human liver cancer
Ning Liang, Tao Yang, Qian Huang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 32
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
N6‐methyladenosine (m6A) modification in gynecological malignancies
Chunmei Zhang, Ning Liu
Journal of Cellular Physiology (2022) Vol. 237, Iss. 9, pp. 3465-3479
Closed Access | Times Cited: 31
AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance
Tianming Qiu, Chenbing Wu, Xiaofeng Yao, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 5, pp. 2165-2181
Open Access | Times Cited: 29
A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions
Ma Yang, Jinguo Wang, Wenping Xiao, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers
Danhua Zhu, Kunkai Su, Xiaoxi Ouyang, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 7, pp. 1553-1570
Open Access | Times Cited: 8
m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma
Lin Zhu, Zhenkun Huang, Jiliang Qiu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top